BOOK
Substance Use Disorders: Part II, An Issue of Child and Adolescent Psychiatric Clinics of North America, E-Book
Ray Chih-Jui Hsiao | Paula D. Riggs
(2016)
Additional Information
Book Details
Abstract
This issue of the Child and Adolescent Psychiatric Clinics will be Part II of II on Substance Use Disorders. Part II will be edited by Drs. Ray Hsiao and Paula Riggs. This portion will focus more on treatments, recovery, and support considerations for adolescents with substance abuse issues. Topics covered include, but are not limited to: screening brief intervention referral treatment in primary care, family-based interventions, motivational enhancement therapy, school-based interventions, contingency management, pharmacotherapy, treatment for children with co-morbid psychiatric issues, special populations, and integration of system of care.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Substance UseDisorders, Part II | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| CONSULTING EDITOR EMERITUS | iii | ||
| FOUNDING CONSULTING EDITOR | iii | ||
| EDITORS | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Preface: The Changing Landscape of Adolescent Substance Treatment\r | vii | ||
| Screening, Brief Intervention, and Referral to Treatment\r | vii | ||
| Family-Based Treatments for Adolescent Substance Use\r | vii | ||
| Cognitive Behavioral Therapy and Motivational Enhancement Therapy\r | vii | ||
| Advances in Research on Contingency Management for Adolescent Substance Use\r | viii | ||
| Meeting Youth Where They Are: Substance Use Disorder Treatment in Schools\r | viii | ||
| Continuing Care for Adolescents in Treatment for Substance Use Disorders\r | viii | ||
| The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders\r | viii | ||
| Cooccurring Psychiatric and Substance Use Disorders\r | ix | ||
| Substance Abuse and Trauma\r | ix | ||
| Substance Use Among College Students\r | ix | ||
| Technology-based Interventions for Preventing and Treating Substance Use Among Youth\r | ix | ||
| Integrated Care for Pediatric Substance Abuse\r | x | ||
| CHILD AND ADOLESCENT\rPSYCHIATRIC CLINICS | xi | ||
| FORTHCOMING ISSUES | xi | ||
| January 2017 | xi | ||
| April 2017 | xi | ||
| July 2017 | xi | ||
| RECENT ISSUES | xi | ||
| July 2016 | xi | ||
| April 2016 | xi | ||
| January 2016 | xi | ||
| Erratum | xiii | ||
| Preface:\rThe Changing Landscape of Adolescent Substance Treatment | xv | ||
| Screening, Brief Intervention, and Referral to Treatment | 579 | ||
| Key points | 579 | ||
| INTRODUCTION | 579 | ||
| SCREENING, BRIEF INTERVENTION, REFERRAL TO TREATMENT IN CHILD AND ADOLESCENT PSYCHIATRY | 581 | ||
| SCREENING | 582 | ||
| SCREENING TOOLS | 582 | ||
| BRIEF INTERVENTION | 587 | ||
| No Use: Positive Reinforcement | 587 | ||
| Lower Risk: Brief Advice | 588 | ||
| Moderate Risk: Brief Intervention | 588 | ||
| Severe Risk: Referral to Treatment | 589 | ||
| CHALLENGES TO SCREENING, BRIEF INTERVENTION, AND REFERRAL TO TREATMENT IMPLEMENTATION | 592 | ||
| SUMMARY | 593 | ||
| REFERENCES | 593 | ||
| Family-Based Treatments for Adolescent Substance Use | 603 | ||
| Key points | 603 | ||
| INTRODUCTION | 603 | ||
| WHY FAMILY-BASED APPROACHES? | 604 | ||
| MULTISYSTEMIC THERAPY | 606 | ||
| Phases of Treatment | 606 | ||
| FUNCTIONAL FAMILY THERAPY | 607 | ||
| Phases of Treatment | 607 | ||
| MULTIDIMENSIONAL FAMILY THERAPY | 608 | ||
| Phases of Treatment | 609 | ||
| BRIEF STRATEGIC FAMILY THERAPY | 610 | ||
| Phases of Treatment | 621 | ||
| OTHER FAMILY THERAPY TREATMENTS | 621 | ||
| SELECTING A TREATMENT | 622 | ||
| SUMMARY | 622 | ||
| REFERENCES | 623 | ||
| Cognitive Behavioral Therapy and Motivational Enhancement Therapy | 629 | ||
| Key points | 629 | ||
| OVERVIEW OF COGNITIVE BEHAVIORAL THERAPY | 629 | ||
| COGNITIVE BEHAVIORAL THERAPY AND SUBSTANCE ABUSE DISORDERS | 630 | ||
| COGNITIVE BEHAVIORAL THERAPY WITH MOTIVATIONAL ENHANCEMENT THERAPY | 635 | ||
| COGNITIVE BEHAVIORAL THERAPY EFFICACY IN ADULTS WITH SUBSTANCE USE | 635 | ||
| COGNITIVE BEHAVIORAL THERAPY EFFICACY IN ADOLESCENTS WITH SUBSTANCE USE DISORDERS | 636 | ||
| ISSUES RELATED TO IMPLEMENTATION | 638 | ||
| Comorbid Diagnoses | 638 | ||
| LIMITATIONS IN TREATMENT | 639 | ||
| IMPLICATIONS FOR CLINICIANS | 640 | ||
| REFERENCES | 640 | ||
| Advances in Research on Contingency Management for Adolescent Substance Use | 645 | ||
| Key points | 645 | ||
| CLINICAL TRIALS TESTING CONTINGENCY MANAGEMENT FOR SUBSTANCE USE DISORDERS | 646 | ||
| Moderators and Mediators | 652 | ||
| Applying Contingency Management to Tobacco Cessation | 652 | ||
| DISSEMINATION AND IMPLEMENTATION OF CONTINGENCY MANAGEMENT FOR ADOLESCENT SUBSTANCE USE | 653 | ||
| Other Indicators of Acceptance of Contingency Management Models | 654 | ||
| CONTINGENCY MANAGEMENT TARGETING OTHER HEALTH BEHAVIORS IN ADOLESCENTS | 655 | ||
| FUTURE DIRECTIONS | 655 | ||
| SUMMARY | 656 | ||
| REFERENCES | 657 | ||
| Meeting Youth Where They Are | 661 | ||
| Key points | 661 | ||
| SCHOOL AS AN IDEAL SETTING FOR MENTAL HEALTH INTERVENTION | 661 | ||
| SCHOOLS OFFER AN OPPORTUNITY TO ADDRESS SIGNIFICANT UNMET NEED FOR TREATMENT | 662 | ||
| SCREENING FOR SUBSTANCE USE DISORDERS IN SCHOOLS | 662 | ||
| INTERVENTIONS: FROM BRIEF INTERVENTION TO INTEGRATED TREATMENT | 663 | ||
| Brief Interventions | 663 | ||
| Randomized, Controlled Trials of Brief Interventions | 664 | ||
| THE NEED FOR MORE ROBUST TREATMENT OF SUBSTANCE USE DISORDERS IN SCHOOLS | 664 | ||
| POTENTIAL BARRIERS TO THE IMPLEMENTATION OF SUBSTANCE ABUSE SERVICES IN SCHOOLS | 665 | ||
| SUMMARY | 666 | ||
| REFERENCES | 666 | ||
| Continuing Care for Adolescents in Treatment for Substance Use Disorders | 669 | ||
| Key points | 669 | ||
| INTRODUCTION | 669 | ||
| RESEARCH ON ADOLESCENT LINKAGE TO CONTINUING CARE SERVICES | 671 | ||
| RESEARCH ON CONTINUING CARE FOR ADOLESCENTS AFTER RESIDENTIAL TREATMENT FOR SUBSTANCE USE DISORDERS | 672 | ||
| Early Studies of Continuing Care | 672 | ||
| Studies of Standard Continuing Care | 672 | ||
| Assertive Continuing Care | 673 | ||
| Research on Continuing Care for Adolescents after Outpatient Treatment for Substance Use Disorders | 674 | ||
| Active Aftercare | 674 | ||
| Assertive Continuing Care | 675 | ||
| ADAPTIVE APPROACHES TO CONTINUING CARE | 675 | ||
| RESEARCH ON OTHER RECOVERY SUPPORTS FOR ADOLESCENTS | 676 | ||
| Volunteer Telephone Continuing Care | 676 | ||
| Mutual Support Groups | 677 | ||
| WHICH ADOLESCENTS BENEFIT MOST FROM CONTINUING CARE? | 677 | ||
| SUMMARY | 678 | ||
| REFERENCES | 679 | ||
| The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders | 685 | ||
| Key points | 685 | ||
| INTRODUCTION | 685 | ||
| The Role of Pharmacotherapy in the Treatment of Substance Use Disorders | 686 | ||
| Treatment of Adolescents Versus Adults: Developing Brains and Different Pharmacokinetics and Pharmacodynamics | 693 | ||
| PHARMACOTHERAPY FOR ALCOHOL USE DISORDERS | 693 | ||
| Pharmacotherapy for Alcohol Withdrawal Syndrome | 694 | ||
| Benzodiazepines | 694 | ||
| Pharmacotherapy for Maintenance Treatment of Alcohol Use Disorders | 694 | ||
| Naltrexone | 694 | ||
| Disulfiram | 695 | ||
| Ondansetron | 695 | ||
| Topiramate | 695 | ||
| Summary of evidence for alcohol use disorders | 696 | ||
| PHARMACOTHERAPY FOR TOBACCO USE DISORDERS | 696 | ||
| Nicotine Replacement Therapy | 696 | ||
| Bupropion | 697 | ||
| Varenicline | 698 | ||
| Summary of Evidence for Tobacco Use Disorders | 699 | ||
| PHARMACOTHERAPY FOR CANNABIS USE DISORDERS | 699 | ||
| N-Acetylcysteine | 699 | ||
| Topiramate | 700 | ||
| Summary of Evidence for Cannabis Use Disorders | 700 | ||
| PHARMACOTHERAPY FOR OPIOID USE DISORDERS | 700 | ||
| Pharmacotherapy for Opioid Withdrawal Syndrome | 701 | ||
| Clonidine and buprenorphine | 701 | ||
| Pharmacotherapy for Maintenance Treatment of Opioid Use Disorders | 701 | ||
| Methadone | 701 | ||
| Buprenorphine | 702 | ||
| Naltrexone | 702 | ||
| Pharmacotherapy for Opiate Overdose | 703 | ||
| Intranasal naloxone | 703 | ||
| Summary of evidence for Opioid Use Disorders | 703 | ||
| SUMMARY | 703 | ||
| REFERENCES | 705 | ||
| Cooccurring Psychiatric and Substance Use Disorders | 713 | ||
| Key points | 713 | ||
| INTRODUCTION | 713 | ||
| Evidence-Based Adolescent Substance Treatment Interventions | 715 | ||
| PROGRESS TOWARD INTEGRATION OF MENTAL HEALTH AND SUBSTANCE TREATMENT | 715 | ||
| TREATMENT OF DEPRESSION IN ADOLESCENTS WITH SUBSTANCE USE DISORDERS | 716 | ||
| TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADOLESCENTS WITH SUBSTANCE USE DISORDERS | 716 | ||
| IMPLICATIONS FOR CLINICAL PRACTICE, INTEGRATED TREATMENT, AND FUTURE RESEARCH | 717 | ||
| SUMMARY | 718 | ||
| REFERENCES | 719 | ||
| Substance Abuse and Trauma | 723 | ||
| Key points | 723 | ||
| INTRODUCTION | 723 | ||
| EPIDEMIOLOGY | 723 | ||
| CLINICAL PRESENTATION | 724 | ||
| Posttraumatic Stress Disorder | 724 | ||
| Substance Use Disorder | 724 | ||
| POSTTRAUMATIC STRESS DISORDER AND SUBSTANCE USE DISORDER: A BIDIRECTIONAL RELATIONSHIP | 725 | ||
| NEUROBIOLOGY | 726 | ||
| DIAGNOSTIC CONSIDERATIONS | 726 | ||
| TREATMENT OVERVIEW | 727 | ||
| Treatment of Posttraumatic Stress Disorder | 727 | ||
| Treatment of Substance Use Disorder | 728 | ||
| INTEGRATED TREATMENT | 728 | ||
| Barriers to Implementation | 729 | ||
| Treatment Components | 729 | ||
| Integration of Systems | 729 | ||
| Cultural Competence | 730 | ||
| CASE DISCUSSIONS | 730 | ||
| Sebastian | 730 | ||
| Case summary | 730 | ||
| Substance Use Among College Students | 735 | ||
| Key points | 735 | ||
| INTRODUCTION | 735 | ||
| EPIDEMIOLOGY OF SPECIFIC DRUGS IN COLLEGE STUDENTS | 736 | ||
| Alcohol | 736 | ||
| Tobacco | 738 | ||
| Marijuana | 738 | ||
| Illicit Drugs Other than Marijuana | 738 | ||
| Prescription Drugs | 738 | ||
| COMPARING COLLEGE STUDENTS WITH PEERS NOT IN COLLEGE | 739 | ||
| DEVELOPMENTAL AND INDIVIDUAL CORRELATES OF SUBSTANCE USE | 739 | ||
| Transition from High School to College | 739 | ||
| Initiation of Drug Use in College | 740 | ||
| First-year College Students | 740 | ||
| Gender | 740 | ||
| Peer Influence | 741 | ||
| Personality Characteristics | 741 | ||
| Interactions Between Other Psychiatric Conditions and Substance Use | 742 | ||
| Engagement in Other Risky Behaviors | 742 | ||
| SPECIAL POPULATIONS | 743 | ||
| Athletes | 743 | ||
| Fraternity or Sorority Involvement | 743 | ||
| Sexual Minorities | 743 | ||
| Racial and Ethnic Minorities | 743 | ||
| PROTECTIVE FACTORS FOR SUBSTANCE USE IN COLLEGE STUDENTS | 744 | ||
| PREVENTION AND INTERVENTION | 744 | ||
| SUMMARY | 746 | ||
| REFERENCES | 746 | ||
| Technology-based Interventions for Preventing and Treating Substance Use Among Youth | 755 | ||
| Key points | 755 | ||
| INTRODUCTION | 755 | ||
| TECHNOLOGY-BASED UNIVERSAL PREVENTION | 756 | ||
| Primary Care Settings | 757 | ||
| School Settings | 758 | ||
| CLIMATE | 758 | ||
| HeadOn | 758 | ||
| Home Setting | 758 | ||
| TECHNOLOGY-BASED SELECTIVE PREVENTION | 759 | ||
| Medical Settings | 759 | ||
| Primary care | 759 | ||
| Emergency room | 759 | ||
| University Setting | 760 | ||
| Personalized normative feedback and technology | 760 | ||
| Other drugs in university settings | 760 | ||
| TECHNOLOGY-BASED TREATMENT | 761 | ||
| Therapeutic Education System | 761 | ||
| Step Up | 761 | ||
| Identifying Therapeutic Opportunities: Ecological Momentary Assessment | 762 | ||
| Educating and Supporting Inquisitive Youth in Recovery | 762 | ||
| Momentary Self-Monitoring and Feedback Motivational Enhancement | 762 | ||
| SUMMARY AND FUTURE DIRECTIONS | 763 | ||
| REFERENCES | 763 | ||
| Integrated Care for Pediatric Substance Abuse | 769 | ||
| Key points | 769 | ||
| INTRODUCTION: INTEGRATED CARE FOR PEDIATRIC SUBSTANCE ABUSE—TIMELY AND DEFINED | 769 | ||
| THE ROLE OF PEDIATRIC PRIMARY CARE | 770 | ||
| PUTTING INTEGRATION INTO PRACTICE: SCREENING, BRIEF INTERVENTION, AND REFERRAL TO TREATMENT | 771 | ||
| Screening | 772 | ||
| Brief Intervention | 772 | ||
| Referral to Treatment | 772 | ||
| CHALLENGES AND OPPORTUNITIES | 773 | ||
| Information Exchange | 773 | ||
| Financial Challenges | 774 | ||
| Role Challenges | 774 | ||
| Evidence Base Challenges | 774 | ||
| SUMMARY | 775 | ||
| REFERENCES | 775 | ||
| Index | 779 |